By coaxing healthy and diseased human bone marrow to become embryonic-like stem cells, a team of Wisconsin scientists has laid the groundwork for observing the onset of the blood cancer leukemia in the laboratory dish.
James Thomson, director of regenerative biology at the Morgridge Institute for Research and a University of Wisconsin–Madison researcher since 1994, learned this week that he is this year's co-winner of the prestigious King Faisal International Prize in Medicine.
A panel of appellate judges removed barriers to embryonic stem cell research funded by federal grants in a decision Thursday, Sept. 9 reversing a suspension of funding ordered in August by another federal judge.
Today the National Institutes of Health reapproved the WiCell Research Institute's H9 (WA09) human embryonic stem (ES) cell line, the most used and cited in scientific research, for ongoing use in federally funded research.
The fifth annual Wisconsin Stem Cell Symposium, called "The Road to Stem Cell Applications: Bioprocessing, Safety and Preclinical Evaluation," will be held on Wednesday, April 21 just outside of Madison.
A year after President Barack Obama issued a landmark executive order to remove eight years of limitations on U.S. federal funding of stem cell research, the WiCell Research Institute has expanded the number of cell lines available through its WISC Bank to 33.
When it comes to stem cell research as a political issue, Wisconsin voters are more likely to be motivated by ideas of economic benefit and scientific progress than by religious objections, according to a new report.
The WiCell Research Institute can continue to provide stem cell scientists one of the earliest and most popular human embryonic stem cell (hESC) lines in the field for their use in federally funded research projects.
The long struggle to move the most versatile stem cells from the laboratory to the clinic got another boost with an $8.8 million contract award to the Waisman Clinical Biomanufacturing Facility at the University of Wisconsin–Madison.
Four advanced pieces of scientific laboratory equipment with a total value of approximately $1 million now are available for use by University of Wisconsin–Madison stem cell and other researchers at several campus departments and centers due to a donation by the private nonprofit WiCell Research Institute.
A team of scientists from the University of Wisconsin–Madison School of Medicine and Public Health has successfully grown multiple types of retina cells from two types of stem cells - suggesting a future in which damaged retinas could be repaired by cells grown from the patient's own skin.
In an advance that could help transform embryonic stem cells into a multipurpose medical tool, scientists at the University of Wisconsin–Madison have transformed these versatile cells into progenitors of white blood cells and into six types of mature white blood and immune cells.
The WiCell Research Institute and the Waisman Clinical Biomanufacturing Facility (WCBF) announced today (July 6) the release of the first current Good Manufacturing Practices (cGMP) feeder-independent pluripotent stem cell banks available for sale and distribution to researchers worldwide.
Pfizer Inc., a major biopharmaceutical company, and the Wisconsin Alumni Research Foundation (WARF), the private, nonprofit patenting and licensing organization for the University of Wisconsin–Madison, announced May 5 that they have signed a license for human embryonic stem (hES) cell patents for the development of new drug therapies.